Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Pharm-Olam’s Centers of Excellence (COEs) have been built to provide an ecosystem of cross-functional, therapeutically aligned teams. Our COEs create synergies and efficiencies that help to ensure your rescue study or trial optimization solutions are optimally positioned to help your clinical trial reach its goals and milestones. Our COEs cover the following specialty research areas:
Our dedicated team of cancer researchers create solutions and provide consulting focused on the needs of your sites and patients – and can bring your study back on track.
Our dedicated staff for infectious disease and vaccine research can support your current sites and tap into our global network to bring your study back on track leveraging our vast expertise from immunizations to immunotherapy.
With more than 100 rare and orphan disease clinical trials completed, we have deep expertise in rare and are prepared to meet the unique challenges of these studies.
Need assistance in other areas? We provide diverse therapeutic expertise in areas such as gastroenterology, neurology/pain, respiratory and allergy to ensure all of the moving parts of your study function seamlessly.
Its time to stop the fall of your study, and get it back on track. When issues like delayed enrollment and timelines, budget problems, regulatory issues and resource constraints threaten to derail your study, our trial optimization or rescue services can help. Specializing in rescue study services requires us to be efficient and move quickly to analyze your study’s needs. From there, we design customized solutions to help get your clinical trial back on track.
Your official transition plan will be initiated by our team of experts from specialized areas who work in parallel to execute regulatory approvals, site agreements and logistical requirements. What’s more, they work to build productive relationships that better position your clinical trial for success.
Since slow recruitment is the number one clinical trial issue, we have a rescue startup team that quickly analyzes your options for enrollment. We also provide you with a global network and decentralized operations model that allows us to quickly initiate sites in countries that typically have far higher rates of recruitment than the U.S. or Western Europe. Whether you need additional sites in an active country, sites in new countries or want to transfer an ongoing study, we can help you meet your enrollment needs.
The best part is that our proven processes and solutions are designed to improve communication between all teams to help alleviate future study issues before they arise.
Looking for assistance on how to plan and execute a rescue scenario? Watch our on-demand webinar - Rescue Your Study: A Sponsor's Playbook.
Taking responsibility for your study is written into the very fabric of our organization. Whether we’re working on your entire study or just one part, we care about the things that impact it and do everything we can to make sure your clinical trial runs smoothly. That’s how our Culture of Accountability supports your study.
When you work with our rescue study team, we provide:
You can depend on our team to deliver the solutions your study needs. To learn more about Why Pharm-Olam is the right CRO partner, click the button below.
Rare Disease Day may have been on 29 February, but at Pharm-Olam, we think it desires an entire...
Learn about Pharm-Olam was contracted to manage and recruit four sites for Phase I, first-in-human research of a PD-1 drug treatment for solid tumor malignancies.
June 6, 2020 – June 10, 2020
London, UK
